Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Different body parts have varying levels of certain hair follicle markers.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

DCPA commonly affects males' lower legs, showing follicular pustules and white areas.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

The document concludes that choosing the right biopsy site is crucial for accurate alopecia diagnosis, and combining methods can improve results.

BCC can protect heart cells from damage caused by oxidative stress.

High ODC and low K1 and K10 may indicate early skin tumors in mice.

Radiological findings help distinguish LAM, PLCH, and BHD to avoid invasive tests.

Poromas are related to sweat duct cells, and CK patterns help distinguish apocrine poromas from other neoplasms.

K15 staining helps distinguish basal cell carcinoma from trichoepithelioma.

Basal cell carcinomas in mice can start from hair follicle stem cells and other skin cell types, depending on signaling levels.

Serum calprotectin is not a reliable marker for alopecia areata activity.

Birt–Hogg–Dubé Syndrome requires genetic testing for accurate diagnosis due to its similarities with tuberous sclerosis.

MAD2B slows down the growth of skin cells that are important for hair development by interacting with TCF4.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

TGF-β1 and 2 may play a role in hair loss in AGA.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

TGF-β1 and 2 in hair follicles may be linked to hair loss in AGA.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Trichoblastomas in rabbits are linked to uncontrolled embryonic hair growth and have distinct histological features.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

A man had bad reactions to a hair loss treatment called DNCB.

Genetic changes in specific proteins contribute to hair loss in some women of African descent.